Shantha Biotech

Sanofi counsels argued that SC's stance in the matter would give clarity to a number of pending tax battles involving cross border transactions.

Shantha Biotech's 5-in-1 vaccine up for WHO review

Shantha Biotech's Shan-5, its 5-in-1 vaccine, disqualified by the WHO on quality concerns, is now up for reassesment.

Sanofi need not pay tax on Shantha Biotech buy: High Court

The Andhra Pradesh High Court (HC) today said that French drug giant Sanofi Aventis need not pay capital gain tax as demanded by Income Tax (I-T) department for acquisition of Shantha Biotech in 2009.

Sanofi seeks French govt aid on Indian acquistion tax

Sanofi Aventis told CNBC-TV18 that it has asked the French government to intercede with the Indian tax department to waive the tax on its acquisition of Shanta Biotech

Shantha Biotech to launch 5-in-1 pediatric vaccine

The world of pediatric vaccines is about to be shaken. And it's Hyderabad based Shantha Biotech that's going to do all the shaking

I am a strong fan of India, says Sanofi-Aventis' CEO

The past few years has seen several multi national pharmaceutical companies come to India looking to make acquisitions. One such company is Sanofi-Aventis who's chief executive officer Chris Viehbacher believes 'India is one of the most exciting countries in the world at this stage.'